Dental Treatment Information

2023 Archives

	Researchers Study Strategies to Increase HIV Testing, Prevention via the Emergency Department Children's Hospital of Philadelphia \| December 5, 2023
	How do I know if I have HIV? aidsmap \| December 2023
	Making the most of a fertile PrEP landscape The Lancet \| December 2023
	PrEP use, HIV testing increased among transgender people from 2014 to 2021 Healio \| December 18, 2023
	A vaginal ring that discreetly delivers anti-HIV drugs will reach more women NPR \| December 8, 2023
	Removing Barriers That Limit Young Men at Risk for HIV Will Improve Access to PrEP Pharmacy Times \| December 5, 2023
	PrEP: Preventative HIV drug highly effective, study says BBC \| December 1, 2023
	The Use of Daily and On-Demand Oral Pre-Exposure Prophylaxis Dosing Strategies Among Young Adult Gay, Bisexual and Other Men who have... AIDS Behav. 2023 Nov;27(11):3632-3644. doi: 10.1007/s10461-023-04077-1
	HIV epidemiology, prevention, treatment, and implementation strategies for public health The Lancet \| November 30, 2023
	NATAP dedicated COVID website section National AIDS Treatment Advocacy Project
	Pre-exposure prophylaxis (PrEP) use history in people with antiretroviral resistance at HIV diagnosis: Findings from New York City HIV... Oxford Academic \| November 17, 2023
	Bc Centre For Excellence In Hiv/Aids Launches New Initiative Targeting Sexually Transmitted Infections in BC Yahoo Finance \| November 17, 2023
	Efficacy and safety of long-acting cabotegravir compared with daily oral tenofovir disoproxil fumarate plus emtricitabine to prevent HIV infection... The Lancet \| November 9, 2023
	Science Update: Generic Daily HIV Prevention Pill for Young Men Who Have Sex with Men ... HIV.gov \| November 6, 2023
	No Longer a Death Sentence, HIV Diagnosis Still Hits Hard Medscape \| November 6, 2023
	HIV/AIDS: Meeting Unmet Needs in Treatment and Prevention United Nations \| November 6, 2023


Courtesy of NATAP
	Predicted uptake of novel HIV treatment options in the United States - (10/16/23)
	Factors driving decisions in the use of HIV Pre-Exposure Prophylaxis: Data from a real-world study in the United States - (10/16/23)
	Increase in New HIV Diagnoses Following Decrease in Use of Pre-exposure Prophylaxis (PrEP) During the COVID-19 Pandemic - (10/16/23)
	The Real-World Impact of Pre-Exposure Prophylaxis (PrEP) Prescription Uptake and Dispensing Status on HIV Infection Risk in the US - (10/16/23)
	Evaluating Pre-Exposure Prophylaxis Use in a Large Integrated Rural US Health System - (10/16/23)
	Facilitators and Barriers to Engaging in PrEP and Gender Affirming Therapy for Black and Latina Transgender Women in South Florida - (10/16/23)
	A Quality Improvement Initiative for HIV Prevention in Underserved Communities - (10/16/23)
	Risk Factors, Risk Perception, and Long-Acting PrEP Awareness and Interest Among US Women: A National Survey - (10/16/23)
	Exploring Cisgender Women's HIV Pre-Exposure Prophylaxis (PrEP) Needs and Preferences Across Settings: the Role of Social-Structural Factors - (10/16/23)
	Integrating Long-Acting Injectable Cabotegravir for PrEP Into Standard of Care for Cisgender Women, Transgender Women, Transgender Men, and Men Who Have Sex With Men: Results From the PILLAR & EBONI Studies - (10/16/23)
	Engaging Black Women on Cabotegravir LA for PrEP by Optimizing Novel Implementation Strategies (EBONI) Study: Provider Perceptions of Appropriateness of Cabotegravir LA for PrEP for Cis-and-Trans Black Women - (10/16/23)
	Healthcare Staff Perceptions of Feasibility and Acceptability on Implementing Injectable HIV Pre-exposure Prophylaxis Into Standard of Care: Baseline Results From the PrEP Implementation Study for Cabotegravir Long Acting for Men in the Real World (PILLAR) - (10/16/23)
	Acceptability of an HIV Pre-Exposure Prophylaxis (PrEP) Shared Decision-Making Tool (SDT) for Diverse Populations and Healthcare Providers - (10/13/23)

	HRSA EHE PrEP data from community health centers (excel) HIV+HEP Policy Institute \| October 19, 2023
	More than a third of eligible beneficiaries on PrEP for HIV, but disparities persist The Hill \| October 17, 2023
	PrEP, a Key HIV Prevention Tool, Isn’t Reaching Black Women KFF Health news \| October 12, 2023
	Missed Chances for Screening in Persons Newly Diagnosed with HIV: New York City, 2018–2022 NEJM \| September 26, 2023
	Primary Care Clinicians Should Spearhead HIV Prevention Medscape \| September 19, 2023
	USPSTF Gives 'A' Rating to All 3 Approved PrEP Medications, but Access Challenges Remain Infectious Disease Special Edition \| September 1, 2023
	HIV Testing Post-Pandemic: Implications to Ending the HIV Epidemic Plan Infectious Disease Special Edition \| September 1, 2023
	Perspectives on long-acting formulations of pre-exposure prophylaxis (PrEP) among men who have sex with men who are non-adherent to daily oral... BMC Public Health. 2023 Aug 28;23(1):1643. doi: 10.1186/s12889-023-16382-4
	New USPSTF Recommendations for HIV PrEP Should Expand Coverage of Affordable Drugs Everyday Health \| August 25, 2023
	PrEParing for the End of the HIV Epidemic—A Public Health Imperative \| Guidelines JAMA Network \| August 22, 2023
	Is Higher Adherence Required for Women using Oral Emtricitabine/Tenofovir Disoproxil Fumarate for HIV Preexposure... Clin Infect Dis. 2023 Aug 17;ciad485. doi: 10.1093/cid/ciad485
	Pre-Exposure Prophylaxis Continues to be Effective in Preventing HIV, Certain Populations ... Pharmacy Times \| August 9, 2023
	Preparing for long-acting PrEP delivery: building on lessons from oral PrEP J Int AIDS Soc. 2023 Jul;26 Suppl 2:e26103. doi: 10.1002/jia2.26103.
	Who prefers what? Correlates of preferences for next-generation HIV prevention products among a national U.S. sample of young men who... J Int AIDS Soc. 2023 Jul;26 Suppl 2(Suppl 2):e26096. doi: 10.1002/jia2.26096.
	Factors Associated With Long-Term Adherence to Daily HIV PrEP Among MSM Infectious Disease Advisor \| July 7, 2023
	Breakthrough HIV-1 infection in setting of cabotegravir for HIV pre-exposure prophylaxis NIH \| PubMed \| July 4, 2023
	PrEP Implant That Protects Against HIV Could Be Near USNews.com \| June 29, 2023
	Disparities in HIV Prevention: New Data Reveal Racial and Regional Gaps in PrEP Usage Contagion Live \| June 28, 2023
	AIDSVu Releases 2022 PrEP Use Data by Race/Ethnicity AIDSVu \| June 21, 2023
	Urging the CDC to Recommend HIV Testing for People 65 and Older POZ Magazine \| June 20, 2023
	Dried blood spot test can detect HIV and hepatitis, researchers say Healio \| April 24, 2023
	PrEP for women in Europe: a systematic literature review HIV Med. 2023 Apr 23. doi: 10.1111/hiv.13458
	DoD Rolls Out Updated HIV PrEP Information HIV.gov \| April 5, 2023
	Willingness to use and preferences for long-acting injectable PrEP among sexual and gender minority populations in the southern United States... J Int AIDS Soc. 2023 Mar;26(3):e26077. doi: 10.1002/jia2.26077.
	Understanding Retention in the HIV Pre-Exposure Prophylaxis Cascade Among Cisgender Women - PubMed (nih.gov) AIDS Patient Care STDS. 2023 Mar 24. doi: 10.1089/apc.2023.0009
	Study examines parental concerns of their sexual and gender minority adolescents using PrEP News Medical \| March 2, 2023
	CDC-UNC Collaboration Yields Potential Long-term HIV Protection UNC Health and UNC School of Medicine \| February 9, 2023
	Agents of change: Long-acting formulations for prevention and treatment of HIV MSF Access Campaign \| February 2, 2023
	Study Suggests Side-Effects and Costs Are Biggest Concerns for Users of HIV Pre-Exposure ... Newswise \| January 31, 2023
	Inconsistent Implementation Of The ACA’s Preventive Services Coverage Requirement Has Resulted In Differential, Unfavorable Coverage For PrEP Health Affairs \| January 26, 2023
	Estimating the impact of HIV PrEP regimens containing long-acting injectable cabotegravir ... The Lancet \| January 17, 2023
	Long-acting PrEP injections could help reduce new cases of HIV in United States Imperial College London \| January 17, 2023

PrEP for women in Europe: a systematic literature review